Intensive pharmacokinetics of the nelfinavir-rifabutin interaction in patients with HIV-related tuberculosis treated with a rifabutin-based regimen
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Efavirenz (Primary) ; Rifabutin (Primary) ; Isoniazid; Nucleoside reverse transcriptase inhibitors
- Indications HIV infections; Tuberculosis
- Focus Pharmacokinetics
- 25 Oct 2005 New trial record.